Navigation Links
NCBiotech Names New President and CEO
Date:8/13/2014

RESEARCH TRIANGLE PARK, N.C., Aug. 13, 2014 /PRNewswire-USNewswire/ -- Douglas L. Edgeton, NCBiotech's senior vice president for financial planning and development with extensive experience in healthcare and economic development, will be the Center's next president and chief executive officer, the Board of Directors announced today.

"Doug's experience demonstrates he knows how to foster an environment that drives small-company growth and job creation," said John Atkins, chairman of the Board of Directors.

Wednesday's announcement caps a six-month search led by board Vice Chairman Jack Cecil.

"Doug's broad background, knowledge of the Center and connections in the state's life science and health community will be key as the Center continues to facilitate job creation and investment in this high-value sector," said Cecil, who is president of Biltmore Farms.

Edgeton was the staff lead on the top-to-bottom examination of NCBiotech operations, requested by the General Assembly and led by former chairman and CEO of GlaxoWellcome Robert A. Ingram. The study documented changes to the Center's structure, staffing and programs following budget cuts. Ingram's committee recommended additional funding for the Center, and the General Assembly increased the Center's appropriation by $1 million this fiscal year.

Prior to joining NCBiotech in 2012, Edgeton was president of the Piedmont Triad Research Park and executive vice president for administration at Wake Forest Baptist Health. There he guided, from concept to completion, the redevelopment of two former Reynolds tobacco warehouses into the state-of-the-art Wake Forest Biotech Place.

Edgeton spent his early career at the University of Alabama at Birmingham, where he held increasingly senior positions, ultimately as the senior associate dean for administration.

"It is an honor to have been selected to lead efforts of the North Carolina Biotechnology Center," Edgeton said.

"Over the past 20 years, my work has focused on developing the ecosystem that advances life science technologies to market. It is easy to see North Carolina is well-positioned to bring solutions to the challenges of healing, feeding and fueling the world. The Biotech Center facilitates these solutions, which have tremendous impact for North Carolina and beyond.

"I look forward to working with all of the companies and people that we serve."

NCBiotech is a private, non-profit corporation supported by the N.C. General Assembly to grow the life science industry.

Editors' Note: Full release and photo available online.


'/>"/>
SOURCE NCBiotech
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
3. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
4. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
5. Codexis Names Wes Bolsen VP and Chief Marketing Officer
6. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
7. Fitzsimons Redevelopment Authority Names New President & CEO
8. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President
9. Laureate Biopharma Names James D. Utterback to Board of Directors
10. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
11. Hospira Names John B. Elliot Senior Vice President of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
Breaking Biology Technology:
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
Breaking Biology News(10 mins):